Previous 10 | Next 10 |
ALACHUA and TAMPA, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, Chairman, Chief Executive Officer, and President, will present at th...
2023-11-09 08:42:11 ET Summary AxoGen, Inc. reported strong Q3 earnings, with sales up 11.6% YoY and beating consensus estimates. AxoGen's sales growth was driven by both demand and price, indicating that unit volumes are keeping up with price increases. AXGN maintained its gu...
2023-11-07 12:51:35 ET Gainers: PaxMedica ( PXMD ) +78% . Jaguar Global Growth Corp I ( JGGC ) +62% . Transmedics Group ( TMDX ) +54% . Baiyu Holdings ( BYU ) +48% . Fathom Digital Manufacturing Corporation ( FATH ) +46% . Ko...
2023-11-07 09:49:02 ET AxoGen, Inc. (AXGN) Q3 2023 Earnings Conference Call November 07, 2023, 08:00 AM ET Company Participants Adanna Alexander - IR Consultant Karen Zaderej - Chairman, CEO and President Pete Mariani - EVP and CFO Conference Call Participa...
2023-11-07 07:11:34 ET More on AxoGen AxoGen, Inc. 2023 Q2 - Results - Earnings Call Presentation AxoGen Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on AxoGen Historical earnings data for AxoGen Financial information for AxoGen ...
ALACHUA, Fla. and TAMPA, Fla., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the third quarter ended September ...
Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...
Axogen Inc. (AXGN) is expected to report $-0.17 for Q3 2023
2023-11-06 14:47:00 ET More on AxoGen AxoGen, Inc. 2023 Q2 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on AxoGen Historical earnings data for AxoGen Financial information for AxoGen For further details see: AxoGen Q3...
ALACHUA, Fla. and TAMPA, Fla., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report third quarter 2023 financial results on Tuesday, November 7, 2...
News, Short Squeeze, Breakout and More Instantly...
ALACHUA and TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report second quarter 2024 financial results on Thursday, August 8, 2024, b...
2024-07-01 07:30:05 ET Raymond James analyst issues OUTPERFORM recommendation for AXGN on July 1, 2024 05:51AM ET. AXGN was trading at $7.24 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 recommendations
ALACHUA, Fla. and TAMPA, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced making an inducement grant on July 1, 2024, under NASDAQ listing rule 5635(c)(4) in conn...